Clinical Trial Update: A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether normalizing vitamin D levels affects major adverse cardiovascular events in patients who have had a myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction
• Stroke

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Death, Myocardial Infarction | Phase 4 | Status: COMPLETED